Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Guofang Lu is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment, particularly through robotic and laparoscopic gastrectomy. His most impactful contribution is the largest systematic review and meta-analysis to date, encompassing data from 68,755 patients, which rigorously compared robotic versus laparoscopic gastrectomy outcomes. This landmark study, published in 2024 and already cited 23 times, provides critical evidence on the safety, efficacy, and potential advantages of robotic surgery in gastric cancer management. Dr. Lu’s work addresses key clinical questions, including postoperative complications, recovery times, and oncological outcomes, helping to guide surgical decision-making worldwide. His scholarly engagement is further demonstrated by his published reply to a letter in *Annals of Surgical Oncology*, where he clarified methodological nuances of his meta-analysis. Through these contributions, Dr. Lu has established himself as a pivotal voice in evidence-based surgical oncology, shaping the future of gastric cancer surgery by systematically evaluating emerging technologies. His research continues to influence both clinical practice and the direction of future trials in minimally invasive gastric cancer treatment.